Acelrx Pharmaceuticals Incの資本の返還
Acelrx Pharmaceuticals Incの資本の返還は何ですか。
Acelrx Pharmaceuticals Incの資本の返還は-131.91%です。
資本の返還の定義は何ですか。
株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
NASDAQのセクタHealth Careにおける資本の返還の企業と比べるAcelrx Pharmaceuticals Inc
Acelrx Pharmaceuticals Incは何をしますか。
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Acelrx Pharmaceuticals Incと類似の資本の返還
- Hertz Globalの資本の返還は-132.17%です。
- Hertz Globalの資本の返還は-132.17%です。
- Epigenomics AGの資本の返還は-132.07%です。
- Anson Resourcesの資本の返還は-132.05%です。
- Tasty Conceptsの資本の返還は-132.02%です。
- Trine II Acquisitionの資本の返還は-131.94%です。
- Acelrx Pharmaceuticals Incの資本の返還は-131.91%です。
- Immunomedicsの資本の返還は-131.88%です。
- Cytosorbents Corpの資本の返還は-131.85%です。
- Zhongtian Internationalの資本の返還は-131.80%です。
- Mirriad Advertising plcの資本の返還は-131.78%です。
- Mercurity Fintech Incの資本の返還は-131.63%です。
- Guyana Goldfieldsの資本の返還は-131.44%です。